DASH PHARMACEUTICALS
Dead / Cancelled — Cancelled — Section 8 (as of 13 Feb 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86984468
- Registration number
- 5822109
- Mark type
- Stylized text
- Filed
- 20 Sept 2014
- Published for opposition
- 02 May 2017
- Registered
- 30 Jul 2019
- Attorney of record
- Michael A. Marrero
Goods and services
- Class 005 — Pharmaceuticals: A pharmaceutical preparation for use in the treatment of anxiety disorders, muscle spasms, and symptoms associated with alcohol withdrawal
Owner
- NATCO PHARMA USA LLC, UPPER SADDLE RIVER, NJ, US
- DASH PHARMACEUTICALS LLC, UPPER SADDLE RIVER, NJ, US
- Fidelity Pharmaceuticals LLC, Upper Saddle River, NJ, US
- Fidelity Pharmaceuticals LLC, Upper Saddle River, NJ, US
- Fidelity Pharmaceuticals LLC, Upper Saddle River, NJ, US
Prosecution history
- 13 Feb 2026 — CANCELLED SEC. 8 (6-YR)
- 30 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 May 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Apr 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 30 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 28 Jun 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jun 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Jun 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Jun 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Apr 2019 — USE AMENDMENT FILED
- 27 Jun 2019 — DIVISIONAL PROCESSING COMPLETE
- 23 Apr 2019 — DIVISIONAL REQUEST RECEIVED
- 27 Jun 2019 — SOU EXTENSION 4 GRANTED
- 23 Apr 2019 — SOU EXTENSION 4 FILED
- 17 Jun 2019 — TEAS STATEMENT OF USE RECEIVED